These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34804944)

  • 1. Establishment of a prognosis Prediction Model Based on Pyroptosis-Related Signatures Associated With the Immune Microenvironment and Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma.
    Jiang A; Meng J; Bao Y; Wang A; Gong W; Gan X; Wang J; Bao Y; Wu Z; Lu J; Liu B; Wang L
    Front Oncol; 2021; 11():755212. PubMed ID: 34804944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Pyroptosis-Related Immune Signatures and Identification of Pyroptosis-Related LncRNA Prognostic Signature in Clear Cell Renal Cell Carcinoma.
    Zhong M; Wang X; Zhu E; Gong L; Fei L; Zhao L; Wu K; Tang C; Zhang L; Wang Z; Zheng Z
    Front Genet; 2022; 13():905051. PubMed ID: 35846134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk of necroptosis and pyroptosis defines tumor microenvironment characterization and predicts prognosis in clear cell renal carcinoma.
    Fu L; Bao J; Li J; Li Q; Lin H; Zhou Y; Li J; Yan Y; Langston ME; Sun T; Guo S; Zhou X; Chen Y; Liu Y; Zhao Y; Lu J; Huang Y; Chen W; Chung BI; Luo J
    Front Immunol; 2022; 13():1021935. PubMed ID: 36248876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyroptosis-Related Subtypes Predict the Response of Clear Cell Renal Cell Carcinoma to Targeted Therapy.
    Ma J; Kang Z; Yang G; Wang X; Si M; Wang Y; Li G; Bai S; Zeng F; Li M; Wang Z; Wang L; Xu W
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):334. PubMed ID: 38179741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel model of pyroptosis-related molecular signatures for prognosis prediction of clear cell renal cell carcinoma patients.
    Chen J; Jiang R; Guan W; Cao Q; Tian Y; Dong K; Pan X; Cui X
    Int J Med Sci; 2024; 21(3):496-507. PubMed ID: 38250606
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction of an interferon regulatory factors-related risk model for predicting prognosis, immune microenvironment and immunotherapy in clear cell renal cell carcinoma.
    Pan H; Lu W; Zhang M; Liu C
    Front Oncol; 2023; 13():1131191. PubMed ID: 37182129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma.
    Huo J; Cai J; Guan G; Liu H; Wu L
    Front Cell Dev Biol; 2021; 9():761839. PubMed ID: 34869350
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of Molecular Heterogeneity Associated With Tumor Microenvironment in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy.
    Zhong W; Li Y; Yuan Y; Zhong H; Huang C; Huang J; Lin Y; Huang J
    Front Cell Dev Biol; 2021; 9():736540. PubMed ID: 34631713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and implementation of a prognostic model for clear cell renal cell carcinoma based on heterogeneous TLR4 expression.
    Zhou Q; Sun Q; Shen Q; Li X; Qian J
    Heliyon; 2024 Feb; 10(4):e25571. PubMed ID: 38380017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling.
    Zhong W; Zhang F; Huang C; Lin Y; Huang J
    J Cancer; 2021; 12(8):2359-2370. PubMed ID: 33758612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma.
    Li Z; Xia Z; Yu Y; Cai L; Jian W; Wang T; Xue W; Wang X; Wang B; Zhang P; Yao W; Zhang C; Wang C
    BMC Med Genomics; 2022 Sep; 15(1):204. PubMed ID: 36163033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma.
    Yao Q; Zhang X; Wei C; Chen H; Xu Q; Chen J; Chen D
    Heliyon; 2023 Jun; 9(6):e17224. PubMed ID: 37360096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma.
    Liu Z; Wang L; Liu L; Lu T; Jiao D; Sun Y; Han X
    Front Oncol; 2021; 11():619242. PubMed ID: 33738257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy.
    Wang Y; Liu J; Zhang L; Li Y
    Dis Markers; 2022; 2022():6402599. PubMed ID: 35845137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Hypoxia-Related Molecular Subtypes in Clear Cell Renal Cell Carcinoma to Aid Immunotherapy and Targeted Therapy
    Zhong W; Zhong H; Zhang F; Huang C; Lin Y; Huang J
    Front Mol Biosci; 2021; 8():684050. PubMed ID: 34250018
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyroptosis Regulators and Tumor Microenvironment Infiltration Characterization in Clear Cell Renal Cell Carcinoma.
    Zhang X; Wei X; Wang Y; Wang S; Ji C; Yao L; Song N
    Front Oncol; 2021; 11():774279. PubMed ID: 35070978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of pyroptosis-related subtypes and comprehensive analysis of characteristics of the tumor microenvironment infiltration in clear cell renal cell carcinoma.
    Zeng J; Zhu P; Tang Y; Zhang C; Ye C; Cheng S; Tian K; Yang B; Zeng W; Liu Y; Xian Z; Yu Y
    Sci Rep; 2023 Sep; 13(1):16055. PubMed ID: 37749171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of pyroptosis regulators and tumor immune microenvironment in clear cell renal cell carcinoma.
    Zhang Y; Chen X; Fu Q; Wang F; Zhou X; Xiang J; He N; Hu Z; Jin X
    Cancer Cell Int; 2021 Dec; 21(1):667. PubMed ID: 34906145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoplasmic Reticulum Stress-Related Signature Predicts Prognosis and Drug Response in Clear Cell Renal Cell Carcinoma.
    Zhang Y; Song Y; Dai J; Wang Z; Zeng Y; Chen F; Zhang P
    Front Pharmacol; 2022; 13():909123. PubMed ID: 35959432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma.
    Jiang A; Cai C; Yang Y; Cui Y; Liu W; Pang Q; Wu Z; Liu B; Qu L; Luo P; Wang A; Wang L
    Oxid Med Cell Longev; 2023; 2023():3077091. PubMed ID: 36825082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.